Malondong, Maryjean .

HRN: 28-11-39  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2026
CEFTRIAXONE 1G (VIAL)
08/17/2026
08/17/2026
IV
2g
PTOR
Pre Op Prophylaxis
Remove - Pending Acceptance
08/17/2026
CEFTRIAXONE 1G (VIAL)
08/17/2026
08/18/2026
IV
2 G
Loading Dose
PROM , Thickly MSAF For CS
Remove - Pending Acceptance
08/17/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/17/2026
08/18/2026
IV
500 Mg
Loading Dose
PROM , Thickly MSAF
Remove - Pending Acceptance
08/17/2026
CEFTRIAXONE 1G (VIAL)
08/18/2026
08/20/2026
IV
2 G
OD
PROM , Thickly MSAF Sp CS
Remove - Pending Acceptance
08/17/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/17/2026
08/18/2026
IV
500 Mg
Q8
PROM , Thickly MSAF
Remove - Pending Acceptance
08/17/2026
CEFUROXIME 500MG (TAB)
08/18/2026
08/25/2026
PO
500 Mg
BID
Sp 1 LTCS
Remove - Pending Acceptance
08/17/2026
METRONIDAZOLE 500MG (TAB)
08/19/2026
08/26/2026
PO
500 Mg
TID
Sp 1 LTCS Thickly Msaf
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: